NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
41 hedge funds and large institutions have $6.01M invested in Navidea Biopharmaceuticals Inc. in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
41% more funds holding
Funds holding: 29 → 41 (+12)
Holders
41
Holding in Top 10
–
Calls
$285K
Puts
$161K
Top Buyers
| 1 | +$981K | |
| 2 | +$344K | |
| 3 | +$258K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$246K |
| 5 |
ACM
Allred Capital Management
Dallas,
Texas
|
+$188K |
Top Sellers
| 1 | -$371K | |
| 2 | -$12.5K | |
| 3 | -$6.15K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$4K |